Elanco Animal Health
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide. The company offers pet health products, such as parasiticides, vaccines, and therapeutics that protect pets from fleas, ticks, and internal parasites under the Seresto, K-9 Advantage, Advantix, and Advocate trademarks; prescription parasiticide … Read more
Elanco Animal Health (ELAN) - Total Assets
Latest total assets as of December 2025: $13.36 Billion USD
Based on the latest financial reports, Elanco Animal Health (ELAN) holds total assets worth $13.36 Billion USD as of December 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Elanco Animal Health - Total Assets Trend (2016–2025)
This chart illustrates how Elanco Animal Health’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Elanco Animal Health - Asset Composition Analysis
Current Asset Composition (December 2025)
Elanco Animal Health's total assets of $13.36 Billion consist of 25.9% current assets and 74.1% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 4.1% |
| Accounts Receivable | $940.00 Million | 7.0% |
| Inventory | $1.74 Billion | 13.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $3.41 Billion | 25.5% |
| Goodwill | $4.78 Billion | 35.8% |
Asset Composition Trend (2016–2025)
This chart illustrates how Elanco Animal Health's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Elanco Animal Health's current assets represent 25.9% of total assets in 2025, an increase from 24.0% in 2016.
- Cash Position: Cash and equivalents constituted 4.1% of total assets in 2025, up from 3.2% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 60.0% of total assets, a decrease from 63.0% in 2016.
- Asset Diversification: The largest asset category is goodwill at 35.8% of total assets.
Elanco Animal Health Competitors by Total Assets
Key competitors of Elanco Animal Health based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
|
USA | $67.26 Billion |
|
Kamada
NASDAQ:KMDA
|
USA | $378.79 Million |
|
One World Pharma Inc
OTCQB:OWPC
|
USA | $6.62 Million |
|
Dongwha Pharm.Co.Ltd
KO:000020
|
Korea | ₩654.63 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥27.28 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥4.97 Billion |
|
Kotra Industries Bhd
KLSE:0002
|
Malaysia | RM363.90 Million |
Elanco Animal Health - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Elanco Animal Health generates 0.35x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Elanco Animal Health is currently not profitable relative to its asset base.
Elanco Animal Health - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.17 | 2.44 | 1.64 |
| Quick Ratio | 1.08 | 1.25 | 0.94 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $1.86 Billion | $ 1.90 Billion | $ 1.31 Billion |
Elanco Animal Health - Advanced Valuation Insights
This section examines the relationship between Elanco Animal Health's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.82 |
| Latest Market Cap to Assets Ratio | 0.88 |
| Asset Growth Rate (YoY) | 5.9% |
| Total Assets | $13.36 Billion |
| Market Capitalization | $11.77 Billion USD |
Valuation Analysis
Near Book Valuation: The market values Elanco Animal Health's assets close to their book value ( 0.88x), suggesting investors view the company's assets at approximately fair value.
Positive Asset Growth: Elanco Animal Health's assets grew by 5.9% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Elanco Animal Health (2016–2025)
The table below shows the annual total assets of Elanco Animal Health from 2016 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $13.36 Billion | +5.90% |
| 2024-12-31 | $12.61 Billion | -12.17% |
| 2023-12-31 | $14.36 Billion | -7.29% |
| 2022-12-31 | $15.49 Billion | -5.99% |
| 2021-12-31 | $16.48 Billion | -6.87% |
| 2020-12-31 | $17.69 Billion | +96.90% |
| 2019-12-31 | $8.99 Billion | +0.32% |
| 2018-12-31 | $8.96 Billion | +0.18% |
| 2017-12-31 | $8.94 Billion | +10.38% |
| 2016-12-31 | $8.10 Billion | -- |